Introduction
============

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder affecting approximately 20% of populations worldwide ([@B25]; [@B6]). One of its features is chronic abdominal pain that is difficult to treat for clinicians. There is short of effective therapeutics for the chronic visceral pain and the exact causes and pathogenesis of IBS are not clear. Many animal models are used to mimic the main pathophysiological features of IBS in humans, one of which is neonatal colonic inflammation (NCI) simulating the effect of early life trauma such as acute bacterial gastroenteritis on the development of visceral sensory ([@B31]; [@B34], [@B35]), which has been reported to generate visceral hyperalgesia in adult rats ([@B31]; [@B23]). Therefore, NCI was used in the present study as an animal model to investigate mechanisms of visceral hypersensitivity of IBS.

Hydrogen sulfide (H~2~S), as one of endogenously occurring gasses, was generated from [L]{.smallcaps}-cysteine by endogenous enzymes such as cystathionine β-synthetase (CBS), cystathionine-γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase ([@B8]; [@B1]). H~2~S has two types of forms *in vivo*: 1/3 in H~2~S gas form and 2/3 in the form of HS^-^. NaHS is dissociated into Na^+^ and HS^-^, which combined with the H^+^ generating H~2~S, and a dynamic balance between H~2~S and NaHS ([@B15]). NaHS, as a donor for H~2~S, is used in many studies ([@B34]; [@B23]). It was reported that CBS-H~2~S signaling played an important role in modulating visceral sensitivity ([@B34]) and somatic sensation ([@B18]; [@B36]). However, the roles were controversial. NaHS was reported to alleviate chronic neuropathic pain in rats with chronic constriction injury ([@B15]) and to inhibit inflammatory hypernociception ([@B3]) in mice as well as to attenuate nociception induced by colorectal distention in adult healthy rats and those after colitis ([@B4]). However, systemic administration of AOAA, an inhibitor of H~2~S synthase, reversed chronic visceral hyperalgesia in adult rats with NCI ([@B23]) rather than enhancing nociception ([@B4]). It is proved that the visceral hyperalgesia of rats with NCI is associated with the up-regulated expression of CBS and the increased excitability of dorsal root ganglion (DRG) neurons ([@B23]). Additionally, it is also proved that the up-regulated expression of CBS and increase in excitation of DRG neurons caused visceral hyperalgesia in adult rats with heterotypic intermittent stress ([@B30]) as well as hyperalgesia in other animal models, such as neonatal maternal deprivation ([@B14]) and diabetes ([@B43]). Therefore, the role of H~2~S in peripheral nervous system seems mainly pro-nociceptive. The analgesia effect of systemic administration of NaHS should be related with the modulation from spinal cord (SC) and/or supraspinal cord. There is little evidence to show the roles of H~2~S in the central nerve system. Many primary afferent neurons with unmyelinated and thinly myelinated fibers projects to the substantia gelatinosa (SG, lamina II) of the dorsal horn of SC ([@B17]; [@B33]). Since much of the afferent signaling by those fibers is nociceptive signals, it is widely speculated that the SG takes an important role in pain mechanisms ([@B17]; [@B7]). CBS and CSE are also expressed in the SC ([@B4]). It is reported that a decrease in spinal H~2~S is pro-nociceptive in the formalin test ([@B13]); the reduction of H~2~S in the SC during diabetes development leads to a hypersensitivity state in neuropathic rats ([@B29]). However, the role of H~2~S at low concentration in SC is pro-nociceptive in LPS-induced mechanical inflammatory hypernociception ([@B3]). So far, it is not clear how the H~2~S in the SC is involved in the regulation of visceral pain.

In the present study, we aimed to clarify the role of H~2~S in SC in a rat model of NCI-induced visceral hypersensitivity. The expression of CBS and CSE in SC was examined by Western blotting techniques from control and NCI rats. Changes in excitatory synaptic transmission were determined using patch-clamp recordings on SG neurons of SC slices. The effect of H~2~S on synaptic transmission and visceral hypersensitivity were explored pharmacologically.

Materials and Methods {#s1}
=====================

Animals
-------

Male Sprague Dawley (SD) rats, 150∼200 g body weight, were housed in plastic cages and under controlled conditions (a 12 h light--dark cycle from 8:00 to 20:00, room temperature: 24 ± 2°C) with a standard rodent diet and fresh water. Care and handling of these animals were approved by the Institutional Animal Care and Use Committee of the Soochow University and were strictly in accordance with the guidelines of the International Association for the Study of Pain. All efforts were made to minimize the suffering and the number of animals. Visceral hypersensitivity was induced by neonatal colonic injection of diluted acetic acid, as described previously ([@B31]; [@B34], [@B35]). In short, 10-day-old pups received an infusion of 0.5% acetic acid solution in 0.2 ml into the colon 2 cm from the anus. Control rats received an equal volume of normal saline (NS). Experiments were performed on these rats at 6∼8 weeks of age.

Spinal Cord Slice Preparation
-----------------------------

Acute SC slices were prepared from adult rats as described previously ([@B42]; [@B38]; [@B16]). The experiments were performed on the colon-related section of SC marked by the afferent nerve fibers of T13-L2 DRGs. The rat was anaesthetized with chloral hydrate (0.4 g/kg, i.p.) and the depth of anesthesia was evaluated by checking the palpebral reflex of animals, and then made an incision on the back. After lumbosacral laminectomy at the level of T13 to L2, the exposed SC was immediately humidified with ice-cold Kreb solution and removed into pre-oxygenated cold Krebs solution (0--4°C) with 95% O~2~ and 5% CO~2~ in a dish. The rats were then killed by exsanguination. The composition of Krebs solution was as follows (in mM): 95 NaCl, 1.8 KCl, 1.2 KH~2~PO~4~, 0.5 CaCl~2,~ 7 MgSO~4,~ 26 NaHCO~3,~ 15 glucose and 50 sucrose, at pH of 7.3--7.4 and an osmolarity of 310--320 mOsm. The ventral, dorsal roots and the pia-arachnoid membrane were removed using microscissors and microforceps under a stereo light microscope. The SC was placed in a shallow groove on an agar block, and the agar block was mounted on the vibrating microslicer stage with cyanoacrylate adhesive. Several transverse slices (450 μm thickness) were cut with a Vibratome (Leica, VT1200S, Germany) while the SC was immersed in cold Krebs solution. The slices were transferred directly to oxygenated Krebs solution at 31°C until use.

Patch-Clamp Recordings from SG Neurons
--------------------------------------

After pre-incubation for 1 h ([@B42]), one slice was placed on a nylon mesh in the recording chamber and fixed with a piece of U-shaped flattened platinum wire with a parallel array of fine nylon threads on top. The slice was continuously perfused with oxygenated recording solution under room temperature at the speed of 10--15 ml/min. The composition of recording solution was as follows (in mM): 127 NaCl, 1.8 KCl, 1.2 KH~2~PO~4~, 2.4 CaCl~2~, 1.3 MgSO~4~, 26 NaHCO~3~ and 15 glucose, at pH of 7.3--7.4 and osmolarity of 300--310 mOsm. The substantia gelatinosa (SG; lamina II) can be indentified as a translucent band across the dorsal horn under the 5x objective (NA 0.10) of an upright microscope (BX51WI, Olympus, Japan). The neurons of SG can be visualized under a 40x magnification water-immersion objective (NA 0.80) with the help of infrared differential interference contrast (IR-DIC) optics. The image of the slice was enhanced with a CCD camera (IR1000E, DAGE MTI) and was displayed on a computer monitor. The patch pipettes were made by a Puller (Sutter-P97, United States). The composition of internal solution of the patch pipette was as follows (in mM): 140 [K]{.smallcaps}-Gluconate, 3 KCl, 10 HEPES, 0.2 EGTA, 4 NaCl, and 2 Ma-ATP. Whole-cell voltage-clamp recordings were made from SG neurons as previously described ([@B40]). The bright and well-shaped cells in SG were chosen. The tip (3∼8 MΩ) was driven down to the slice by a micromanipulator (MP-225). After giga ohm (GΩ) seals (usually 2∼8 GΩ) were formed and the whole-cell configuration was obtained, neurons were tested if the resting membrane potential was more negative than -50 mV and direct depolarizing current injections (0∼200 pA, step 40 pA, duration 500 ms) evoked action potentials (APs) overshooting 0 mV when recording excitatory post-synaptic currents (EPSCs) and Aps ([@B39]). The resting membrane potential was determined immediately after cell membrane rupture ([@B2]). The neurons were holding at -70 mV for recording spontaneous excitatory post-synaptic currents (sEPSCs). Miniature EPSCs (mEPSCs) were recorded in the presence of TTX (1 μM) in the recording solution. Although H~2~S could be produced endogenously, it is presumed to exist at very low concentrations in animal tissues due to its toxicity ([@B22]). Therefore, NaHS was used at 2.5 μM in the present study. CNQX (10 μM) was also applied in some experiments to identify the property of EPSC. Drugs were dissolved in ACSF from stocks on the day of experiment and added by perfusion. Signals were acquired using a Multiclamp 700B amplifier, Digidata 1440A interface and ClampEx10.3 software (Molecular Devices, Axon, United States) and filtered at 5 kHz with Bessel filter of amplifier. Data were stored on a computer for offline analysis. The data of inhibitory neurons were not included in the present analysis. The inhibitory neurons can be classified as its tonic firing pattern ([@B2]). In all cases, n refers to the number of neurons recorded.

Real-time qPCR
--------------

Total RNA was exacted from the dorsal horn of T13-L2 SC in control and NCI rats by Trizol method. cDNA was synthesized from total RNA using EasyScript First-Strand cDNA Synthesis SuperMix kit (Transgen Biotech) following the instructions. qPCR was conducted according the protocol of TransStart Tip Green qPCR SuperMix kit (Transgen Biotech). Negative control reactions were performed by omitting cDNA temple. The relative expression level for each target gene was normalized via 2^-ΔΔCt^ method.

Western Blotting
----------------

The expression of CBS in spinal dorsal horn corresponding to afferent nerve fibers from DRGs (T~13~-L~2~) for adult NCI and control rats (6--8 week old) were determined using western blot analyses as described previously ([@B22]). In short, the tissue of spinal dorsal horn were lyzed in radioimmunoprecipitation assay buffer containing 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS, PMSF (10 μl/ml) and aprotinin (30 μl/ml; Sigma). The lysates were then microfuged for 30 min at 4°C. After fractionating of SC protein extract on 4 and 10% polyacrylamide gels, proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). Membranes were then blocked in Tris-buffered saline (TBS) containing 5% dilution of non-fat milk powder under room temperature. Membrane of 55--72 KD was incubated with anti-CBS antibody (1:1000; Abnova, Taiwan, China) and the membrane of 35--55 KD was incubated with anti-GAPDH antibody (1:1000; Goodhere, China) under 4°C overnight in TBS containing 1% milk. After washed in TBS containing 0.5% Tween-20 (TBST), membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (1:4000; Chemicon) in TBS containing 1% milk at room temperature. The membrane was then washed with TBST and the immunoreactive proteins were detected by enhanced chemiluminescence (ECL kit; AmershamBiosciences, Arlington Heights, IL, United States) and appropriate exposure to chemiluminescent imaging system (ChemiDoc XRS, Biorad). Band intensities were measured using Image J software. All samples were normalized to GAPDH as loading control.

Drug Application
----------------

For behavioral experiments, *O*-(carboxymethyl)hydroxylamine hemihydrochloride (AOAA, an inhibitor of CBS) was purchased from Sigma-Aldrich and freshly prepared in NS (0.9% wt/vol NaCl). At the age of 5 week, AOAA was injected intrathecally at 10 μg/kg body weight, one time per day for a consecutive 7 days as described previously ([@B23]).

Statistical Analysis
--------------------

A fixed length of trace (5 min) that contains more than 300 events was analyzed using MiniAnalysis program 6.0.3 (Synaptosoft) for frequency and amplitude distributions of miniature and spontaneous EPSCs. After the automatical detection for peaks, each detected event was visually checked to exclude the false data. Three to four times the root mean square value of its background noise was set to be the detection threshold for an event in a set of data. Cumulative fractions were calculated before and after an addition of a drug. Kolmogorov--Smirnov test was used to analyze EPSCs. Data are presented as the means ± SEM. Error bars in the figures stand for SEM. Normality was checked for all data before using the Mann--Whitney test as *post hoc* test following Friedman ANOVA, two-sample *t*-test and paired sample Wilcoxon signed rank test with Origin 8 (Origin Lab, Inc., United States), as appropriate. Statistical significance was determined as *P* \< 0.05.

Results
=======

Upregulated Expression of CBS in Spinal Cord of NCI Rats
--------------------------------------------------------

CVH was determined by measuring AWR scores in response to colorectal distention (CRD) at age of 6 week for control (CON, *n* = 8) and NCI (*n* = 8) rats. AWR scores were significantly higher for NCI rats at different distention pressures (20, 40, 60, and 80 mmHg) when compared with those of age-matched controls (**Figure [1A](#F1){ref-type="fig"}**, Control group: 0.63 ± 0.18, 1.38 ± 0.26, 1.88 ± 0.23, 2.38 ± 0.32 for 20, 40, 60, and 80 mmHg, respectively; NCI group: 2.00 ± 0.27, 2.5 ± 0.19, 2.75 ± 0.25, 3.38 ± 0.26 for 20, 40, 60, and 80 mmHg, respectively; ^∗^*P* \< 0.05, for the same pressure, use Mann--Whitney test as *post hoc* test following Friedman ANOVA). It suggested that NCI significantly induced visceral hypersensitivity in adult rats. This result was consistent with the previous report from our group ([@B23]).

![Upregulated expression of CBS in spinal cord (SC) of NCI rats. **(A)** NCI treatment significantly increased AWR scores to CRD at age of 6 weeks compared with the age-matched control rats (*n* = 8). **(B)** Increase in expression of CBS in SC at T13-L2 levels from NCI rats at age of 6 week compared with control (CON) rats (*n* = 5 for control group and *n* = 8 for NCI group). **(C)** No difference of CBS mRNA expression in SC between CON and NCI rats at age of 6 weeks (*n* = 5). **(D)** No difference of CSE expression in SC at T13-L2 level between CON and NCI rats at age of 6 weeks (*n* = 5). **(E)** No difference of CBS expression in SC at T7-T10 level between CON and NCI rats at age of 6 weeks (*n* = 4). **(F)** No difference of CBS expression in dorsal root ganglion (DRG) at L4-L6 level between CON and NCI rats at age of 6 weeks (*n* = 4). ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 when compared with CON.](fphar-08-00696-g001){#F1}

Since H~2~S is an important mediator in both peripheral and central nervous systems in various types of pain, and its synthase CBS, which has much higher activity than CSE ([@B4]), is expressed in SC. Western blotting assays were performed to determine whether expression of CBS was changed in SC after NCI. Anti-CBS antibody labeled a ∼60 kDa molecular mass protein (**Figure [1B](#F1){ref-type="fig"}**). At 6 weeks of the age, relative densitometry of CBS was 1.83 ± 0.26 (*n* = 5) for control and 3.76 ± 0.37 (*n* = 8) for NCI group, respectively. It suggested that the expression of CBS was significantly upregulated after NCI (**Figure [1B](#F1){ref-type="fig"}**, ^∗∗^*P* \< 0.01, two-sample *t*-test). However, the mRNA level of CBS was not significantly altered after NCI (**Figure [1C](#F1){ref-type="fig"}**, *n* = 5 for each group). Also, there was no change in the expression of CSE (∼70 kDa) in SC between control and NCI group (**Figure [1D](#F1){ref-type="fig"}**, *n* = 5 for each group, *P* \> 0.05, two-sample *t*-test; 0.77 ± 0.03 for control; 0.78 ± 0.08 for NCI). The expression of CBS in T7-10 SC (*n* = 4, **Figure [1E](#F1){ref-type="fig"}**) and at L~4-6~ DRGs (*n* = 4, **Figure [1F](#F1){ref-type="fig"}**) was not altered after NCI. Thus, NCI remarkably increased CBS expression in SC corresponding to the afferents of T~13~-L~2~ DRGs when compared with that of age-matched control rats.

NCI Enhanced the Excitation of SG Neurons
-----------------------------------------

Whether the intrinsic excitatory property of SG neurons was changed by NCI was examined by whole-cell patch-clamp recordings in acutely prepared transverse lumbar SC slices from control and NCI rats. Among the SG neurons recorded (*n* = 109, 70 from control slices, 39 from NCI slices), different discharge patterns were observed, including tonic-firing, delayed-firing, gap-firing, initial-bursting, bursting and phasic firing, as previously reported ([@B41]; [@B24]). SG neurons recorded from control (15.7%, 11/70) and from NCI group (15.4%, 6/39) belong to tonic-firing neurons. Since most inhibitory neurons are reported to show tonic-firing pattern ([@B2]), the SG neurons who showed tonic-firing pattern was excluded from later analysis, and the data from neurons of other firing patterns were pooled together to analyze the property of excitatory neurons. The representative traces for three different current stimuli from two typical neurons illustrated that the excitation of SG neurons was increased by NCI (**Figure [2A](#F2){ref-type="fig"}**). The average results were shown in **Figure [2B](#F2){ref-type="fig"}**. The number of APs of control SG neurons (*n* = 17) under 40, 80, and 120 pA current stimulation was 8.23 ± 1.45, 20.53 ± 1.93, and 28.73 ± 2.47, respectively. The number of APs of NCI SG neurons (*n* = 18) under 40, 80, and 120 pA current stimulation was 17.00 ± 2.04, 37.44 ± 2.48, and 52.12 ± 4.29, respectively. It suggested that the excitability of SG neurons was significantly increased by NCI (**Figure [2B](#F2){ref-type="fig"}**; ^∗∗^*P* \< 0.01; two sample *t*-test for each current stimulation). In addition, the mean resting membrane potential for CON neurons was -60.71 ± 0.73 mV (*n* = 59) and -59.36 ± 0.95 mV (*n* = 33) for NCI neurons. They did not differ significantly (**Figure [2C](#F2){ref-type="fig"}**, *P* \> 0.05, two sample *t*-test). However, the AP threshold for NCI neurons (-34.11 ± 0.84 mV, *n* = 35) significantly hyperpolarized when compared with that of the CON neurons (-31.56 ± 0.53 mV, *n* = 20, **Figure [2D](#F2){ref-type="fig"}**, ^∗∗^*P* \< 0.01, two sample *t*-test). Rheobase reflects the minimal injected current to evoke an AP. The rheobase of SG neurons was 13.89 ± 2.88 pA and 28.00 ± 1.99 pA for NCI and CON group, respectively. It suggested that NCI dramatically decreased the rheobase (**Figure [2E](#F2){ref-type="fig"}**, ^∗∗^*P* \< 0.01, two sample *t*-test), which is consistent with the increased excitation of SG neurons by NCI.

![NCI increased the excitation of SG neurons. **(A)** Representative traces of APs caused by three different depolarizing current stimulation (40, 80, and 120 pA) in SG neurons from CON and NCI rats. **(B)** NCI greatly increased the frequency of APs elicited by current injection of 40, 80, and 120 pA compared with controls. *n* = 17 for control group and *n* = 18 for NCI group, ^∗^*P* \< 0.05 vs. CON, ^∗∗^*P* \< 0.01 vs. CON. **(C)** The mean resting membrane potential (RP) had no significant difference between CON and NCI rats (*n* = 59 for control group and *n* = 33 for NCI group). **(D)** There was significant hyperpolarization in action potential (AP) threshold between CON and NCI rats. *n* = 35 for control group and *n* = 20 for NCI group, ^∗∗^*P* \< 0.01. **(E)** NCI significantly decreased the rheobase when compared with CON. *n* = 35 for control group and *n* = 20 for NCI group, ^∗∗^*P* \< 0.01.](fphar-08-00696-g002){#F2}

NCI Enhanced Spontaneous Excitatory Neurotransmission of SG Neurons
-------------------------------------------------------------------

Since the excitation of SG neurons was enhanced by NCI, the excitatory neurotransmission was presumed to be enhanced by NCI as well. The sEPSCs of SG neurons were then compared between control and NCI group. The representative traces from two typical neurons of control and NCI slices illustrated an increase in frequency of sEPSCs of SG neuron in NCI group (**Figure [3A](#F3){ref-type="fig"}**). The average results were also shown in **Figure [3B](#F3){ref-type="fig"}**. Mean frequency of sEPSCs averaged to 4.44 ± 0.74 Hz in control group and 7.66 ± 1.17 Hz in NMD group, respectively (**Figure [3B](#F3){ref-type="fig"}** left, *n* = 29 for control, *n* = 35 for NCI, ^∗^*P* \< 0.05, two sample *t*-test). In parallel, the mean peak amplitude of sEPSCs averaged to 20.16 ± 1.13 pA in control group and 20.44 ± 1.02 pA in NMD group, respectively (**Figure [3B](#F3){ref-type="fig"}**, right, *n* = 29 for control, *n* = 35 for NCI, *P* \> 0.05, two sample *t*-test). The sEPSCs can be completely blocked by CNQX (10 μM, **Figure [3C](#F3){ref-type="fig"}**). It suggested that the AMPA receptor-mediated glutamatergic synaptic activity was significantly enhanced in SG of NCI rats.

![NCI increased the frequency of sEPSCs in SG neurons. **(A)** Representative traces of spontaneous excitatory post-synaptic currents (sEPSC) recorded from SG neurons hold at --70 mV in voltage clamp from control (CON) and NCI rats. **(B)** NCI increased the frequency of sEPSC (left, ^∗^*P* \< 0.05, compared with CON) but failed to change the amplitude of sEPSC (right) when compared with controls (*n* = 29 for control group and *n* = 35 for NCI group). **(C)** The administration of CNQX (10 μM) blocked all the sEPSCs in SG neurons from control rats. a: An expanded trace for sEPSC recorded in the absence of CNQX. b: An expanded trace for sEPSC recorded in the presence of CNQX.](fphar-08-00696-g003){#F3}

NaHS Enhanced sEPSCs of SG Neurons in Control Slices
----------------------------------------------------

Since CBS were upregulated and the excitability of SG was increased in NCI group, we presumed that NaHS, a donor of H~2~S, could increase the excitatory neurotransmission of SG in SC slices of control rats. NaHS (2.5 μM) were perfused for 5 min after recording the pretreated data for at least 5 min. The two enlarged traces of a typical current trace illustrated the increase in frequency of sEPSCs in a neuron of SG in control slices (**Figure [4Aa,b](#F4){ref-type="fig"}**). NaHS had no significant effect on the amplitude of sEPSCs (**Figures [4B,C](#F4){ref-type="fig"}**, left; *P* \> 0.05, paired sample Wilcoxon signed rank test). Mean amplitudes averaged to 23.21 ± 1.58 pA before and 24.1 ± 1.73 pA after addition of NaHS (104.78 ± 5.57%, *n* = 10, *P* \> 0.05, paired sample Wilcoxon signed rank test). Kolmogorov--Smirnov test proved that NaHS shifted the cumulative fraction of inter-event intervals of sEPSCs toward smaller value (**Figure [4B](#F4){ref-type="fig"}**, right) and increased the mean frequency of sEPSC significantly (**Figure [4C](#F4){ref-type="fig"}**, right; *n* = 9, ^∗^*P* \< 0.05, paired sample Wilcoxon signed rank test). There was a significant increase in average frequency from 5.53 ± 1.63 Hz before, to 6.31 ± 1.88 Hz after the addition of NaHS. The average increase achieved 123.24 ± 9.13%. It suggested that NaHS application increased the spontaneous glutamatergic synaptic activity of SG neurons in control rats.

![NaHS enhanced the frequency of sEPSCs in control group. **(A)** Representative current traces of sEPSCs recorded in the presence and absence of NaHS (2.5 μM). a: An expanded trace for sEPSC recorded in the absence of NaHS; b: a expanded trace for sEPSC recorded in the presence of NaHS. **(B)** Cumulative distribution analysis of amplitude and inter-event intervals from one representative SG neuron. NaHS had no discernible effect on the amplitude, but NaHS caused a notably shift toward shorter inter-event intervals (*n* = 10, *P* \< 0.05, Kolmogorov--Smirnov test). **(C)** Bar plot showing NaHS significantly increased mean frequency of sEPSC without change in peak amplitude. *n* = 9, ^∗^*P* \< 0.05.](fphar-08-00696-g004){#F4}

Presynaptic Effect of NaHS
--------------------------

To assess whether presynaptic or post-synaptic mechanism underlies the effect of NaHS in SG, we used a well-established method, the quanta analysis of miniature EPSCs. The frequency and amplitude of mEPSCs of SG from control rats were measured before and after application of NaHS (2.5 μM). The typical trace and its two expanded traces of a representative neuron showed that NaHS increased the frequency of mEPSCs recorded in SG neurons of control slices (**Figure [5A](#F5){ref-type="fig"}**). NaHS didn't significantly affect the amplitude of mEPSCs (**Figures [5B,C](#F5){ref-type="fig"}**, left). Mean amplitudes averaged to 25.96 ± 1.87 pA before and 24.53 ± 0.99 pA after addition of NaHS (96.49 ± 3.5%, *n* = 10, *P* \> 0.05, paired sample Wilcoxon signed rank test). Kolmogorov--Smirnov test proved that NaHS shifted the cumulative fraction of inter-event intervals of mEPSCs toward smaller value (**Figure [5B](#F5){ref-type="fig"}**, right) and significantly increased the mean frequency of mEPSC (**Figure [5C](#F5){ref-type="fig"}**, right, *n* = 10, ^∗^*P* \< 0.05, paired sample Wilcoxon signed rank test). There was a significant increase in average frequency from 4.51 ± 0.5 Hz before, to 5.56 ± 0.67 Hz after the addition of NaHS. The average increase achieved 124.14 ± 11.58%. It is well-known that change in frequency of mEPSCs reflects the increase of presynaptic neurotransmitter release, whereas change in amplitude of mEPSCs reflects the changes at the post-synaptic membrane ([@B19]; [@B42]). The result of mEPSCs suggested that the effect of NaHS application in control slices is most likely presynaptic.

![NaHS enhanced the frequency of mEPSCs in control group. **(A)** Representative current traces of mEPSCs recorded in the presence and absence of NaHS (2.5 μM). Na^+^ channel blocker TTX (1 μM) was used in Kreb solution. a: An expanded trace for mEPSC recorded in the absence of NaHS; b: an expanded trace for mEPSC recorded in the presence of NaHS. **(B)** Cumulative distribution analysis of peak amplitude and inter-event intervals from the same neuron showed that NaHS reduced the inter-event intervals of mEPSC (*n* = 10, *P* \< 0.01, Kolmogorov--Smirnov test) but had no effect on the amplitude. **(C)** Bar plot showing NaHS significantly increased mean frequency of sEPSCs but not amplitude. *n* = 10, ^∗^*P* \< 0.05.](fphar-08-00696-g005){#F5}

AOAA Treatment Reversed the Enhanced sEPSCs and Visceral Hypersensitivity
-------------------------------------------------------------------------

Since CBS were upregulated and the excitability of SG was increased in NCI rats, we hypothesized that the increase of excitability of SG in NCI rats might be associated with the upregulation of CBS. Therefore, inhibition of CBS was hypothesized to decrease excitability of SG in NCI rats. AOAA, an inhibitor of CBS, was intrathecally injected in the present study to determine the effect of inhibiting CBS on sEPSCs of SG neurons in NCI slices. Data were compared with the sEPSCs of SG neurons in slices from NS-treated NCI rats. The representative traces from two typical neurons of NS and AOAA treated group illustrated a decrease in frequency of sEPSCs of SG neuron in AOAA group (**Figure [6A](#F6){ref-type="fig"}**). The average results were also shown in **Figure [6B](#F6){ref-type="fig"}**. The mean peak amplitude of sEPSCs averaged to 19.03 ± 1.42 pA in NCI group and 20.33 ± 1.48 pA in AOAA group, respectively (**Figure [6B](#F6){ref-type="fig"}** left, *n* = 10 for NS, *n* = 9 for AOAA, *P* \> 0.05, two sample *t*-test). In parallel, mean frequency of sEPSCs averaged to 5.05 ± 0.71 Hz in NCI group and 2.64 ± 0.66 Hz in AOAA group, respectively (**Figure [6B](#F6){ref-type="fig"}** right, *n* = 10 for NS, *n* = 9 for AOAA, ^∗^*P* \< 0.05, two sample *t*-test). It suggested that the glutamatergic synaptic activity was significantly decreased in SG of AOAA-treated NCI rats.

![AOAA decreased the frequency of sEPSCs in SG neurons and attenuated visceral pain of NCI-rats. **(A)** Representative traces of sEPSCs recorded from SG neurons holding at --70 mV in voltage clamp from NCI and AOAA-treated rats. **(B)** AOAA treatment didn't change the amplitude of sEPSC compared with NCI rats. The frequency of sEPSC was decreased after AOAA treatment compared with NCI rats. *n* = 10 for NS, *n* = 9 for AOAA, ^∗^*P* \< 0.05. **(C)** Bar plot showing that intrathecal injection of AOAA significantly decreased AWR scores of NCI rats. *n* = 5, ^∗^*P* \< 0.05. **(D)** Bar plot showing that intrathecal injection of NaHS significantly increased AWR scores of control rats. *n* = 6, ^∗^*P* \< 0.05.](fphar-08-00696-g006){#F6}

We then detected the effect of AOAA treatment on visceromotor responses to CRD in NCI rats. Intrathecal injection of AOAA significantly attenuated AWR scores at different distention pressures in NCI rats when compared with NS group (**Figure [6C](#F6){ref-type="fig"}**, *n* = 5 for each group, ^∗^*P* \< 0.05, use Mann--Whitney test as *post hoc* test following Friedman ANOVA; NS group: 1.9 ± 0.19, 2.3 ± 0.25, 2.9 ± 0.24, 3.2 ± 0.2 for 20, 40, 60, and 80 mmHg, respectively; AOAA group: 1.1 ± 0.24, 1.5 ± 0.16, 2.1 ± 0.19, 2.5 ± 0.16 for 20, 40, 60, and 80 mmHg, respectively). These data proved that AOAA treatment reversed the visceral hypersensitivity in NCI rats. It is in compliance with the result of our previous study ([@B23]).

Since NaHS/H~2~S was proved to increase the glutamatergic synaptic transmission of SG neurons of control slices in the present study. We presumed that NaHS application could induce visceral hypersensitivity of control rats as well. NaHS solution (2.5 μM) was intrathecally injected into SC (L~5-6~) for consecutive 7 days and the behavioral responses were assessed. The AWR scores for all the distension pressure are significantly higher than the corresponding values of NS-treated rats (**Figure [6D](#F6){ref-type="fig"}**, *n* = 6, ^∗^*P* \< 0.05, Mann--Whitney test as *post hoc* test following Friedman ANOVA; NS, 0.5 ± 0.16, 1.1 ± 0.19, 1.7 ± 0.2, 2.1 ± 0.19 for 20, 40, 60, and 80 mmHg, respectively; NaHS, 1.4 ± 0.19, 1.9 ± 0.19, 2.5 ± 0.16, 3.1 ± 0.29 for 20, 40, 60, and 80 mmHg, respectively). These data demonstrate that NaHS/H~2~S induced hyperalgesic effect in healthy rats, which supports the pronociceptive effect of CBS upregulation in NCI rats.

Discussion
==========

The pathogenesis of chronic visceral pain in patients with IBS remains largely unknown. The present study demonstrates that hydrogen sulfide signaling at SC level produces visceral hypersensitivity in adult rats with NCI. The conclusion is based on the following observations: (1) NCI leads to a significant increase in expression of CBS in SC where receives input from T13-L2 DRG neurons (**Figure [1B](#F1){ref-type="fig"}**); (2) NCI significantly increases neuronal excitability and excitatory synaptic transmission in SG of spinal dorsal horn (**Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}**); (3) Intrathecal injection of AOAA (the antagonist of CBS) not only reversed the visceral hyperalgesia of rats with NCI but also decreased excitatory synaptic transmission in SG (**Figure [6](#F6){ref-type="fig"}**); (4) Intrathecal injection of NaHS (2.5 μM) not only led to visceral pain but also significantly increases excitatory synaptic transmission of SG in control rats (**Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}**). These results indicate that upregulation of CBS expression contributed to enhanced synaptic transmission at SG neurons and visceral hypersensitivity of adult rats with NCI.

Although much attention has been drawn to study the roles of H~2~S, there is yet no consensus on this topic. Reports on H~2~S in pain processing are controversial. It is reported that H~2~S at physiological levels in SC plays an anti-nociceptive role through inhibition of microglial function both in formalin-induced mechanical pain ([@B13]) and in neuropathic pain of rats during diabetes development ([@B29]). Hydrogen sulfide prevents opioid withdrawal-induced pain sensitization ([@B37]). However, the H~2~S of low concentration in SC in LPS-induced mechanical inflammatory hypersensitivity is pro-nociceptive ([@B3]). The role of H~2~S in SG in NCI-induced visceral hyperalgesia is consistent with that in LPS-induced mechanical inflammatory hypernociception, indicating that the modulatory role of H~2~S in SC on pain is attributed to the pain model. In the present study, the increase in frequency of mEPSCs by NaHS, without significant change in amplitude of mEPSCs, strongly suggested that these effects were attributable to the action at presynaptic site of SG (**Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}**). The action site of H~2~S is consistent with that in other tissues, such as neuromuscular junction ([@B9]) and superior mesenteric ganglion ([@B26]). Since H~2~S increased presynaptic glutamate neurotransmission, upregulation of CBS contributed to the over excitation of SG in NCI rats. It is reported that the effect of H~2~S in mouse neuromuscular junction is mediated by intracellular Ca^2+^ and cAMP signaling and involves presynaptic ryanodine receptors ([@B9]). The mechanism of H~2~S action on synaptic transmission in SG may be similar to that reported in mouse neuromuscular junction and further studies are definitely needed. Since glial activation is a common mechanism underlying spinal synaptic plasticity ([@B44]), future investigation into the roles of H~2~S on glial-neuronal interaction is very important.

In the present study, since NaHS or AOAA were injected intrathecally, these drugs may act on SC and/or DRGs. It is therefore difficult to rule out the contribution of DRGs. However, by considering the data obtained by the electrophysiological recordings from the SG neurons of spinal dorsal horn, it is reasonable to hypothesize that SC might be one of the important action sites for H~2~S. CBS and CSE are two important endogenous synthetases for H~2~S. Both CBS and CSE are expressed in the SC ([@B4]). CBS is reported to be localized to astrocytes-enriched tissues such as hippocampus, temporal lobe, and cortex ([@B5]; [@B21]). In SC, CBS might also be localized to astrocytes although it lacks direct evidence. The activity of CBS is reported to be 30-fold greater than that of CSE ([@B4]). We showed here that CBS in SC is dramatically upregulated while CSE expression was not significantly altered (**Figure [1](#F1){ref-type="fig"}**), indicating CBS might be a major factor contributing to visceral hyperalgesia of NCI rats. However, the mRNA level of CBS was not altered. Reasons for this discrepancy might include: regulation of CBS expression at mRNA and protein levels may not happen at the same time and the CBS protein degradation speed was changed. In the present study, the upregulation of CBS expression at translational level and/or downregulation of protein degradation speed might be the underlying mechanisms. In addition, the protein level of CBS is not equal to endogenous H~2~S since endogenous H~2~S in the nervous system is generated from CBS, CSE and 3MST.

H~2~S has multiple molecular targets in peripheral tissues and in the CNS. Spinal and peripheral H~2~S activates L-type channel ([@B28]), T-type Ca^2+^ channels (such as Cav3.2 channel) in the primary afferents and/or spinal nociceptive neurons ([@B18]). It also elevates the intracellular Ca^2+^ levels through activation of TRPA1 channels in capsaicin-sensitive DRG neurons ([@B8]), thus leading to [L]{.smallcaps}-glutamate release enhancement in SG neurons and sensitization of nociceptive processing ([@B10]). Phosphorylation of spinal ERK underlies the development of visceral pain ([@B20]). H~2~S also promotes the activation of NMDA receptors via stimulation of cyclic adenosine monophosphate (cAMP)/protein kinase A signaling and/or inhibition of phosphodiesterase ([@B8]), leading to the facilitation of nociceptive synaptic efficacy in spinal dorsal horn ([@B32]). On the other hand, some ion channels, receptors and transcription factors are involved in the anti-nociciptive effect of H~2~S. The activation of ATP dependent K^+^ channels ([@B11]) and GABAb receptors ([@B22]) by H~2~S could result in an increase of K^+^ conductance, which might inhibit visceral nociception in response to colorectal distension in rats ([@B11]). The H~2~S donor Na~2~S was reported to activate the mu-opioid receptor MOR ([@B27]). The inhibition of NF-κB by H~2~S could inhibit microglial activation, thus preventing the development of neuropathic pain ([@B12]). ATF3 and expression of pCREB can be inhibited by H~2~S in the SC to alleviate chronic neuropathic pain ([@B15]; [@B12]). The precise mechanism that underlies the present results still needs to be further studied in the future.

Conclusion
==========

The present study shows that the upregulation of CBS in SC takes part in visceral hypersensitivity of adult rats with NCI through a presynaptic mechanism by increasing excitatory neurotransmission and sensitizing the SG neurons. Inhibiting H~2~S signaling in SC can alleviate the visceral pain induced by CRD. The present results shed light on the role of H~2~S in SC in development of visceral hypersensitivity and provide new insights into the treatment of chronic visceral pain in patients with IBS.
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